Family Focused Therapy for Teens at Risk for Bipolar Disorder

Sponsor
Sunnybrook Health Sciences Centre (Other)
Overall Status
Terminated
CT.gov ID
NCT02355366
Collaborator
(none)
2
1
2
43.9
0

Study Details

Study Description

Brief Summary

The present study aims to examine the effects of a 4 month, family focused therapy (FFT) intervention on the 1 year course of mood symptoms in offspring of parents with bipolar disorder (BD). The study will also examine the level of expressed emotion among families and how this impacts on FFT treatment outcomes. This study seeks to replicate a previous study by Miklowitz, Schneck, Singh, Taylor, George and colleagues (2013), which demonstrated the efficacy of FFT among BD offspring. Importantly, the present study will introduce biological measures that predict and reflect improvement in symptoms and expressed emotion. These markers reflect stress-related biological systems and include saliva samples to ascertain cortisol, interleukin-6 (IL-6) and salivary alpha amylase (sAA).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Family-Focused Therapy
  • Behavioral: Brief Educational Treatment
N/A

Detailed Description

Children of parents with bipolar disorder (BD) have increased risk of developing BD themselves. BD in youth is associated with increased risk for suicidality, psychosis, substance abuse and compromised psychosocial functioning. In addition, offspring of parents with BD have an increased vulnerability for developing other psychopathology (e.g. major depression). At present, research examining early intervention and treatment for this high risk population is limited. However, a recent study in symptomatic youth at risk for BD indicated that participation in a family focused therapy (FFT) intervention led to positive treatment outcomes. The present study aims to examine the effects of FFT in BD offspring in comparison to a brief educational treatment. Specifically, this study will examine whether FFT can have protective effects on individuals' mood symptoms and functioning by targeting the family environment. We will expand upon previous research by also measuring biological markers of stress (i.e., cortisol levels) and changes in family functioning over time. With this knowledge, the results of this study may help to shed light on the importance of early intervention and improve preventative treatment options for youth at high-risk for bipolar disorder.

Study Design

Study Type:
Interventional
Actual Enrollment :
2 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Family Focused Therapy (FFT) for Adolescents at Familial Risk for Bipolar
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Nov 26, 2018
Actual Study Completion Date :
Nov 26, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Family Focused Therapy (FFT)

Participants will receive Family-Focused Therapy (FFT). It will consist of twelve, 1-hour long sessions, over a period of 4 months. The 12 sessions will include psychoeducation (sessions 1-4), training in communication enhancement (sessions 5-8) and training in relation to problem-solving skills (sessions 9-12).

Behavioral: Family-Focused Therapy
Family Focused Therapy is a manual-based, psycho-educational intervention which is designed to reduce intra-familial stress, conflict, and affective arousal by enhancing communication and problem solving skills among families who are affected by bipolar disorder (Miklowitz et al., 2013). It concentrates on skills relevant to managing the prodromal stages of bipolar disorder, such as mood monitoring, reducing family conflict, improving problem solving, stabilizing daily routines and regulating sleep/wake cycles (Miklowitz, 2012).
Other Names:
  • FFT
  • Family Therapy
  • Psychosocial Intervention
  • Psychoeducaton
  • Psychotherapy
  • Behaviour Therapy
  • Active Comparator: Brief Educational Treatment

    Participants will be receive 1-2 educational sessions which will include diagnostic feedback, recommendations for further treatment and crisis intervention if required.

    Behavioral: Brief Educational Treatment
    Brief Educational Treatment will consist of 1 - 2 sessions involving both parents and adolescents; it will consist of diagnostic feedback following the adolescent's baseline assessment. It will provide families with information and strategies on tracking and managing adolescent mood disorders. Additionally, ongoing medication management and crisis family sessions will be available if required.
    Other Names:
  • Psychoeducation
  • Diagnostic Evaluation
  • Crisis Management
  • Outcome Measures

    Primary Outcome Measures

    1. KSADS Mania Rating Scale (KMRS) [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Measures symptom severity.

    2. KSADS Depression Section (KDRS) [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Measures symptom severity.

    3. Adolescent Longitudinal Interval Follow-up Evaluation (A-LIFE) [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Used to track symptom severity, treatment (both psychosocial and psychotropic), self-injurious/suicidal behavior and psychosocial functioning over time.

    4. The Family Environment Scale (FES) [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Examines each family member's perceptions of the family in three ways-as it is (real), as it would be in a perfect situation (ideal) and as it will probably be in new situations (expected).

    5. Family Adaptability & Cohesion & Adaptability Scale (FACES) [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Evaluate the adaptability and cohesion dimensions in family interactions.

    6. Conflict Behaviour Questionnaire (CBQ) [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Measures conflict and negative communication between parents and adolescents.

    7. Issues Checklist [Change from baseline to endpoint (assessed at 0, 4 and 12 months)]

      Measures potential areas of conflict between parents and adolescents.

    8. Cortisol [Change from baseline to endpoint (assessed at 0, 4, and 12 months)]

      Stress-related biomarker obtained through saliva samples.

    9. Interleukin 6 (IL-6) [Change from baseline to endpoint (assessed at weeks 0, 4, and 12 months)]

      Stress-related biomarker obtained through saliva samples.

    10. Alpha Amylase [Change from baseline to endpoint (assessed at 0, 4, and 12 months)]

      Stress-related biomarker obtained through saliva samples.

    11. Five Minute Speech Sample [Change from baseline to endpoint (assessed at 0, 4, and 12 months)]

      Assesses level of expressed emotion (EE) within the parental household.

    12. Emotional Response to Conflict Scale (ERCS) [Change from baseline to endpoint (assessed at 0, 4 and 12 months)]

      Assesses individuals' emotional responses to a brief, laboratory based, conflict negotiation task.

    Secondary Outcome Measures

    1. Children Global Assessment Scale [Change from baseline to endpoint (assessed at 0, 4, 8 and 12 months)]

      Quantifies overall level of functioning for a child or adolescent during a specified time period.

    2. Anthromorphic Data [Change from baseline to endpoint (Assessed at weeks 0 and 12 months)]

      Measures height, weight, body mass index, & blood pressure.

    3. Working Alliance Inventory Short-Revised (WAI-SR) [Change from baseline to endpoint. For FFT Group: Assessed after therapy sessions 1, 4, 8 & 12. For Education Control Group: Assessed after therapy sessions 1 & 2.]

      Measures therapeutic alliance.

    4. General Information Sheet [Baseline]

      Demographics

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    13 Years to 19 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    1. English-speaking males and females of any race/ethnicity

    2. 13-19 years of age

    3. Have at least 1 biological parent who meets diagnostic criteria for bipolar disorder (BD) type I or II, based on the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I)

    4. Adolescent is experiencing current, significant mood symptoms indicated by a psychiatric status rating (PSR) score of 3

    5. At least 1 parent/primary caregiver is available to attend sessions.

    All participants will complete rigorous diagnostic interviews to ensure that they meet these requirements.

    Exclusion Criteria:
    1. Unable to provide informed consent (e.g., severe psychosis, developmental delay)

    2. Have met the DSM-IV criteria (based on the Schedule for Affective Disorders and Schizophrenia for School Age Children, Present and Life Version - K-SADS-PL), for substance dependence in the past 3 months (excluding nicotine dependence)

    3. Are victims of current sexual or physical abuse by parents or live among domestic violence

    4. For offspring, already meet criteria for bipolar disorder (BD) type I or II.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sunnybrook Health Sciences Centre Toronto Ontario Canada M4N 3M5

    Sponsors and Collaborators

    • Sunnybrook Health Sciences Centre

    Investigators

    • Principal Investigator: Benjamin Goldstein, MD, Sunnybrook Health Sciences Centre

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Dr. Benjamin Goldstein, Associate Professor, University of Toronto, Sunnybrook Health Sciences Centre
    ClinicalTrials.gov Identifier:
    NCT02355366
    Other Study ID Numbers:
    • 404-2014
    First Posted:
    Feb 4, 2015
    Last Update Posted:
    Jan 22, 2019
    Last Verified:
    Jan 1, 2019
    Keywords provided by Dr. Benjamin Goldstein, Associate Professor, University of Toronto, Sunnybrook Health Sciences Centre
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 22, 2019